Novartis Faces Generic Challenge To Heart Drug Patent
By Hanna Vioque ( July 1, 2026, 6:34 PM BST) -- Generics drugmaker Stada has asked a London judge to clear the way for it to launch a generic version of Novartis' blockbuster heart failure treatment called Entresto by nixing several of the pharmaceutical giant's patents. ...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.